Population
Patients with vasovagal syncope
Design
Review
Authors
Loading...
Facilitates rigorous vasovagal syncope trial design; leaves open identification of effective therapies pending powered studies.
This review outlines the methodological requirements, risk stratification, and outcome measures necessary for designing adequately powered clinical trials in vasovagal syncope.
Robert S. Sheldon (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: